1,3-Dimethyl 5,5-dicyano-4-(4-fluorophenyl)-2-hydroxy-6-phenylcyclohex-1-ene-1,3-dicarboxylate

Catalog No. :
ACTIIX509
CAS No. :
1212220-50-2
Molecular Formula :
C24H19FN2O5
Molecular Weight :
434.42

IUPAC Name:dimethyl 2',2'-dicyano-4''-fluoro-5'-hydroxy-1',2',3',4'-tetrahydro-[1,1':3',1''-terphenyl]-4',6'-dicarboxylate

1,3-Dimethyl 5,5-dicyano-4-(4-fluorophenyl)-2-hydroxy-6-phenylcyclohex-1-ene-1,3-dicarboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$322.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1,3-Dimethyl 5,5-dicyano-4-(4-fluorophenyl)-2-hydroxy-6-phenylcyclohex-1-ene-1,3-dicarboxylate
IUPAC Namedimethyl 2',2'-dicyano-4''-fluoro-5'-hydroxy-1',2',3',4'-tetrahydro-[1,1':3',1''-terphenyl]-4',6'-dicarboxylate
MDL No.MFCD04125291
Molecular FormulaC24H19FN2O5
Molecular Weight434.42
SMILESO=C(C1=C(O)C(C(OC)=O)C(C2=CC=C(F)C=C2)C(C#N)(C#N)C1C3=CC=CC=C3)OC
InChI KeyPRXFMTTUJTWQJI-UHFFFAOYSA-N
SynonymDIMETHYL 5,5-DICYANO-4-(4-FLUOROPHENYL)-2-HYDROXY-6-PHENYL-1-CYCLOHEXENE-1,3-DICARBOXYLATE;1,3-dimethyl 5,5-dicyano-4-(4-fluorophenyl)-2-hydroxy-6-phenylcyclohex-1-ene-1,3-dicarboxylate;1-Cyclohexene-1,3-dicarboxylic acid, 5,5-dicyano-4-(4-fluorophenyl)-2-hydroxy-6-phenyl-, 1,3-dimethyl ester
CAS No.1212220-50-2

Synthetic Route by SureRoute

1. ACTIIX509 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTIIX509 route product structure diagram
    ACTIIX5091212220-50-2
Inquiry

2. ACTIIX509 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTIIX509 route product structure diagram
    ACTIIX5091212220-50-2
Inquiry

Comments (0)